Clementine Perrier

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA.

Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA.

Journal: BMJ open
Published: March 13, 2024

Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease.

Effects of Epithelial IL-13Rα2 Expression in Inflammatory Bowel Disease.

Journal: Frontiers in immunology
Published: October 24, 2018

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial.

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial.

Journal: Lancet (London, England)
Published: May 13, 2014

Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's disease.

Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's disease.

Journal: PloS one
Published: May 03, 2013

Butyricicoccus pullicaecorum in inflammatory bowel disease.

Butyricicoccus pullicaecorum in inflammatory bowel disease.

Journal: Gut
Published: December 25, 2012

New drug therapies on the horizon for IBD.

New drug therapies on the horizon for IBD.

Journal: Digestive diseases (Basel, Switzerland)
Published: October 19, 2012

Neutralization of membrane TNF, but not soluble TNF, is crucial for the treatment of experimental colitis.

Neutralization of membrane TNF, but not soluble TNF, is crucial for the treatment of experimental colitis.

Journal: Inflammatory bowel diseases
Published: June 01, 2012

Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab.

Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab.

Journal: Immunology
Published: February 07, 2012

Cytokine blockade in inflammatory bowel diseases.

Cytokine blockade in inflammatory bowel diseases.

Journal: Immunotherapy
Published: November 08, 2011
Showing 1-9 of 9

Last Updated: 09/26/2026